4//SEC Filing
Congleton Jon 4
Accession 0001644975-25-000006
CIK 0001933414other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 5:07 PM ET
Size
7.0 KB
Accession
0001644975-25-000006
Insider Transaction Report
Form 4
Congleton Jon
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Stock Option
2025-11-21−24,082→ 0 totalExercise: $0.54Exp: 2031-03-11→ Common Stock (24,082 underlying) - Exercise/Conversion
Common Stock
2025-11-21$0.54/sh+24,082$13,004→ 655,387 total
Footnotes (2)
- [F1]Due to a rounding error, the exercise price for this stock option was originally reported as $0.53 per share on the Reporting Person's Form 3 filed on February 9, 2023.
- [F2]The stock option vested with respect to 25% of the underlying shares on March 12, 2022 and the remaining shares in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Mineralys Therapeutics, Inc.
CIK 0001933414
Entity typeother
Related Parties
1- filerCIK 0001644975
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 5:07 PM ET
- Size
- 7.0 KB